Literature DB >> 11259432

IgE receptor type I-dependent tyrosine phosphorylation of phospholipid scramblase.

C Pastorelli1, J Veiga, N Charles, E Voignier, H Moussu, R C Monteiro, M Benhamou.   

Abstract

To identify new effectors of IgE receptor (FcepsilonRI) signaling, we purified proteins from FcepsilonRI-stimulated RBL-2H3 rat mast cells on anti-phosphotyrosine beads and generated mouse monoclonal antibodies (mAb) against these proteins. Two mAbs bound to a protein that was identified as a new isoform of phospholipid scramblase (PLSCR) after screening an RBL-2H3 cDNA expression library. This isoform differed from PLSCR1 by the absence of an exon 3-encoded sequence and by an insert coding six QGPY(P/A)GP repeats. The PLSCR family of proteins is responsible for a redistribution of phospholipids across the plasma membrane. Although rat PLSCR is a 37-kDa protein, anti-phosphotyrosine immunoblots revealed the presence of 37-49 kDa phosphoproteins in the material immunoprecipitated with either anti-PLSCR mAb but not with unrelated monoclonal or polyclonal antibodies. Depletion of PLSCR resulted in the absence of these phosphoproteins. Additional experiments led to the identification of these phosphoproteins as phospho-PLSCR itself. Stimulation of RBL-2H3 cells upon FcepsilonRI engagement resulted in a dramatic increase in PLSCR tyrosine phosphorylation. A comparison of the relative amounts of phospho-PLSCR and nonphosphorylated PLSCR demonstrated that only a tiny fraction was thus modified, indicating a finely targeted involvement of PLSCR in FcepsilonRI signaling. Thus, this study reports the cloning of a new isoform of PLSCR, as well as the first observation that a member of the PLSCR family is a target for tyrosine kinases and is involved in signaling by an immune receptor. These findings open new perspectives on the role of phospholipid scramblases and to the mechanisms involved in their regulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259432     DOI: 10.1074/jbc.M100790200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Identification of phospholipid scramblase 1 as a biomarker and determination of its prognostic value for colorectal cancer.

Authors:  Yung-Bin Kuo; Chung-Chuan Chan; C Allen Chang; Chung-Wei Fan; Ray-Ping Hung; Ya-Shu Hung; Kuei-Tien Chen; Jau-Song Yu; Yu-Sun Chang; Err-Cheng Chan
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

2.  Phospholipid scramblase 1 potentiates the antiviral activity of interferon.

Authors:  Beihua Dong; Quansheng Zhou; Ji Zhao; Aimin Zhou; Ronald N Harty; Santanu Bose; Amiya Banerjee; Roger Slee; Jeanna Guenther; Bryan R G Williams; Therese Wiedmer; Peter J Sims; Robert H Silverman
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 3.  Beyond apoptosis: the mechanism and function of phosphatidylserine asymmetry in the membrane of activating mast cells.

Authors:  Noel M Rysavy; Lori M N Shimoda; Alyssa M Dixon; Mark Speck; Alexander J Stokes; Helen Turner; Eric Y Umemoto
Journal:  Bioarchitecture       Date:  2014

4.  Nuclear phospholipid scramblase 1 prolongs the mitotic expansion of granulocyte precursors during G-CSF-induced granulopoiesis.

Authors:  Chun-Wei Chen; Mark Sowden; Qian Zhao; Therese Wiedmer; Peter J Sims
Journal:  J Leukoc Biol       Date:  2011-03-29       Impact factor: 4.962

5.  Drosophila melanogaster Scramblases modulate synaptic transmission.

Authors:  Usha Acharya; Michael Beth Edwards; Ramon A Jorquera; Hugo Silva; Kunio Nagashima; Pedro Labarca; Jairaj K Acharya
Journal:  J Cell Biol       Date:  2006-04-10       Impact factor: 10.539

6.  Fertilization induces a transient exposure of phosphatidylserine in mouse eggs.

Authors:  Claudio A Curia; Juan I Ernesto; Paula Stein; Dolores Busso; Richard M Schultz; Patricia S Cuasnicu; Débora J Cohen
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

7.  Blockade of phospholipid scramblase 1 with its N-terminal domain antibody reduces tumorigenesis of colorectal carcinomas in vitro and in vivo.

Authors:  Chung-Wei Fan; Chun-Yu Chen; Kuei-Tien Chen; Chia-Rui Shen; Yung-Bin Kuo; Ya-Shan Chen; Yeh-Pin Chou; Wei-Shan Wei; Err-Cheng Chan
Journal:  J Transl Med       Date:  2012-12-24       Impact factor: 5.531

8.  The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane.

Authors:  Bénédicte Py; Stéphane Basmaciogullari; Jérôme Bouchet; Marion Zarka; Ivan C Moura; Marc Benhamou; Renato C Monteiro; Hakim Hocini; Ricardo Madrid; Serge Benichou
Journal:  PLoS One       Date:  2009-03-31       Impact factor: 3.240

9.  Regulation of the tyrosine phosphorylation of Phospholipid Scramblase 1 in mast cells that are stimulated through the high-affinity IgE receptor.

Authors:  Asma Kassas; Ivan C Moura; Yumi Yamashita; Jorg Scheffel; Claudine Guérin-Marchand; Ulrich Blank; Peter J Sims; Therese Wiedmer; Renato C Monteiro; Juan Rivera; Nicolas Charles; Marc Benhamou
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

10.  Phospholipid Scramblase 1 Modulates FcR-Mediated Phagocytosis in Differentiated Macrophages.

Authors:  Cecile Herate; Ghania Ramdani; Nancy J Grant; Sabrina Marion; Stephane Gasman; Florence Niedergang; Serge Benichou; Jerome Bouchet
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.